FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Amy Chappell

Research Profile

Chemicals & Drugs

Concepts & Ideas

Procedures

Double-Blind Method

Disorders

Devices

Placebos

Co-author Network

Publications

TOP 3
Amy S Chappell; Durisala Desaiah; Hong Liu-Seifert; Shuyu Zhang; Vladimir Skljarevski; Yuri Belenkov; Jacques P Brown
A double-blind, randomized, placebo-controlled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the knee.
Vladimir Skljarevski; Durisala Desaiah; Hong Liu-Seifert; Qi Zhang; Amy S Chappell; Michael Detke; Smriti Iyengar; Joseph H Atkinson; Misha-Miroslav Backonja
Efficacy and safety of duloxetine in patients with chronic low back pain.
Vladimir Skljarevski; Shuyu Zhang; Amy S Chappell; Daniel J Walker; Isabelle Murray; Misha-Miroslav Backonja
Maintenance of effect of duloxetine in patients with chronic low back pain: a 41-week uncontrolled, dose-blinded study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Amy Chappell (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Amy S Chappell; Durisala Desaiah; Hong Liu-Seifert; Shuyu Zhang; Vladimir Skljarevski; Yuri Belenkov; Jacques P Brown
A double-blind, randomized, placebo-controlled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the knee.
Pain practice : the official journal of World Institute of Pain 2011;11(1):33-41.
2010: Vladimir Skljarevski; Durisala Desaiah; Hong Liu-Seifert; Qi Zhang; Amy S Chappell; Michael Detke; Smriti Iyengar; Joseph H Atkinson; Misha-Miroslav Backonja
Efficacy and safety of duloxetine in patients with chronic low back pain.
Spine 2010;35(13):E578-85.
2010: Vladimir Skljarevski; Shuyu Zhang; Amy S Chappell; Daniel J Walker; Isabelle Murray; Misha-Miroslav Backonja
Maintenance of effect of duloxetine in patients with chronic low back pain: a 41-week uncontrolled, dose-blinded study.
Pain medicine (Malden, Mass.) 2010;11(5):648-57.
2009: Amy S Chappell; Melissa J Ossanna; Hong Liu-Seifert; Smriti Iyengar; Vladimir Skljarevski; Linda Chunhong Li; Robert M Bennett; Harry Collins
Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial.
Pain 2009;146(3):253-60.
2009: Vladimir Skljarevski; Durisala Desaiah; Qi Zhang; Amy S Chappell; Michael Detke; Jorge L Gross; Dan Ziegler
Evaluating the maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic pain.
Diabetes/metabolism research and reviews 2009;25(7):623-31.
2009: Ernest H S Choy; Philip J Mease; Daniel K Kajdasz; Madelaine M Wohlreich; Paul Crits-Christoph; Daniel J Walker; Amy S Chappell
Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials.
Clinical rheumatology 2009;28(9):1035-44.
2009: Vladimir Skljarevski; M Ossanna; Hong Liu-Seifert; Q Zhang; Amy S Chappell; Smriti Iyengar; Michael Detke; M Backonja
A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2009;16(9):1041-8.
2009: Madelaine M Wohlreich; Mark D Sullivan; Craig H Mallinckrodt; Amy S Chappell; Tina M Oakes; John G Watkin; Joel Raskin
Duloxetine for the treatment of recurrent major depressive disorder in elderly patients: treatment outcomes in patients with comorbid arthritis.
Psychosomatics 2009;50(4):402-12.
2009: Lesley M Arnold; James I Hudson; Fujun Wang; Madelaine M Wohlreich; Apurva Prakash; Daniel K Kajdasz; Amy S Chappell
Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder.
The Clinical journal of pain 2009;25(6):461-8.
2009: Amy S Chappell; Geoffrey Littlejohn; Daniel K Kajdasz; Morton Scheinberg; Deborah N D'Souza; Harvey Moldofsky
A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia.
The Clinical journal of pain 2009;25(5):365-75.
2008: Amy S Chappell; Laurence A Bradley; Curtis G Wiltse; Michael Detke; Deborah N D'Souza; Michael Spaeth
A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia.
International journal of general medicine 2008;1():91-102.
2007: Joachim F Wernicke; Fujun Wang; Yili Lu Pritchett; Timothy R Smith; Joel Raskin; Deborah N D'Souza; Smriti Iyengar; Amy S Chappell
An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain.
Pain medicine (Malden, Mass.) 2007;8(6):503-13.
2007: David Armstrong; Amy S Chappell; Trong K Le; Daniel K Kajdasz; Misha-Miroslav Backonja; Deborah N D'Souza; James M Russell
Duloxetine for the management of diabetic peripheral neuropathic pain: evaluation of functional outcomes.
Pain medicine (Malden, Mass.) 2007;8(5):410-8.
2007: Dan Ziegler; Yili Lu Pritchett; Fujun Wang; Durisala Desaiah; Michael J Robinson; Jerry A Hall; Amy S Chappell
Impact of disease characteristics on the efficacy of duloxetine in diabetic peripheral neuropathic pain.
Diabetes care 2007;30(3):664-9.
2004: Christine N Sang; N M Ramadan; R G Wallihan; Amy S Chappell; Frederick G Freitag; T R Smith; Stephen D Silberstein; Kirk W Johnson; Lee A Phebus; David Bleakman; Paul Ornstein; B Arnold; S J Tepper; F Vandenhende
LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraine.
Cephalalgia : an international journal of headache 2004;24(7):596-602.
2000: Ian Gilron; Mitchell B Max; G Lee; Susan Booher; Christine N Sang; Amy S Chappell; Ray Dionne
Effects of the 2-amino-3-hydroxy-5-methyl-4-isoxazole-proprionic acid/kainate antagonist LY293558 on spontaneous and evoked postoperative pain.
Clinical pharmacology and therapeutics 2000;68(3):320-7.
1998: Christine N Sang; M P Hostetter; Richard H Gracely; Amy S Chappell; D D Schoepp; G Lee; S Whitcup; R Caruso; Mitchell B Max
AMPA/kainate antagonist LY293558 reduces capsaicin-evoked hyperalgesia but not pain in normal skin in humans.
Anesthesiology 1998;89(5):1060-7.